United States · Funded startup

Who invested in Selah Genomics

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$750Kraised across 2 rounds since 2013, from 2 sources

$300KSeries A$450KDebt

Latest round: Debt, $450KMar 2016
Step-upi: 1.5×
Investors: 2

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201420152016

$300KSeries A$450KDebt

First round: Series A, $300K
Biggest round: $450K
Between rounds: 2.8 years

The rounds

Mar 2016
Debt$450K1 new
- VentureSouth
Source recordedSEC filing: $450K sold, first sale Feb 2016
Jun 2013
Series A$300K1 new
- Upstate Carolina Angel Network
Reported by medcitynews.comSEC filing: $300K sold, first sale May 2013

Founders and team

From the SEC filings it signed: 2 on the team.

Jeremy S. StuartExecutive Officeri
Michael S. BolickExecutive Officer, Directori

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2013Debt2016

VentureSouth

Upstate Carolina Angel Network

The exit

ExitBuyerPriceWhen

AcquiredEKF diagnosticsundisclosedMar 2014

From historical deal records. Wrong? Tell us.

Everyone who backed them

VentureSouthAngel network1round

Upstate Carolina Angel NetworkAngel network1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Selah Genomics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

NMT CapitalVC firmPer its own site